Korea Biomedical Review

Researchers from the Institute for basic science (IBS) and Sungkyunkwan University have developed a shape-morphing, cortex-adhesive electronic patch that adapts in real-time to brain wave changes, offering a more precise and personalized treatment for brain diseases compared to traditional methods. https://lnkd.in/gM9bXbvj

Navigating academic pressures and mental health struggles reveals a critical issue in Korea's mental health care system. Many find that available support falls short of their needs, exacerbated by deep-rooted stigma that leaves individuals feeling isolated. This starkly contrasts to more accepting approaches in countries like the U.S., where mental health discussions are normalized. As Korea grapples with the highest suicide rates among OECD countries, it's clear that breaking the stigma and enhancing access to tailored mental health care are essential for progress. https://lnkd.in/gmfgSD8S

The Ministry of Health and Welfare (MOHW) issued a notice last Sunday stating that healthcare workers would not be held liable for refusing emergency room treatment under certain conditions. The guidelines state that violence or the threat of violence in the emergency room is a valid reason to deny treatment. This includes cases of assault, threats against medical staff, or damage to medical equipment or facilities. Additionally, healthcare professionals may refuse treatment if the patient or their guardians create a situation that could lead to charges of insult, defamation, assault, or obstruction of duty, making it impossible for the medical team to provide proper care. Another valid reason for refusing treatment involves non-emergency cases. The guidelines specify that medical staff will not be held accountable for turning away patients classified as low-priority (Class 4 and 5) non-emergency cases under Korea's five-tier severity classification system. Conditions such as the common cold, gastroenteritis, or diarrhea fall into this category.

Daewoong Pharmaceutical, Daewoong Bio Inc., and Daewoong Therapeutics, have been selected as the primary and co-sponsors for the 2024 Material Component Technology Development Project. This initiative, organized by the Ministry of Trade, Industry and Energy, aims to localize raw material production for #hyperlipidemia treatments. https://lnkd.in/gav2TMBq

Inventage Lab, a Korean biotechnology company specializing in microsphere long-acting injectable and lipid nanoparticle (LNP), announced its collaboration on the co-development of a long-acting injectable formulation for peptide-based drug candidates with Boehringer Ingelheim. "This joint development project is significant because, unlike the typical scenarios where a small biotech company proposes a specific pipeline to a multinational pharmaceutical company, in this case, the multinational pharmaceutical company selected a technology provider based on its own needs and requirements to advance the formulation,” an Inventage Lab official said. “Therefore, the likelihood of Boehringer Ingelheim’s final commercialization of this joint development project is expected to be substantial."

Kyung Hee University Medical Center (KHUH) said it will collaborate with 카카오헬스케어 - kakaohealthcare in a government-led project to develop artificial intelligence (AI)-based healthcare services for children and adolescents, with a particular focus on allergies, growth, and obesity. 

Takeda Korea announced on Thursday that Peter Trang has been appointed as the new head of Business Operations, a division responsible for analyzing corporate capabilities and setting goals from an enterprise-wide perspective. Mr. Trang joined Takeda Pharmaceuticals Australia in 2016 as Business Insights Manager.

Recent research published in Geroscience reveals that #Helicobacter pylori, a bacterium affecting two-thirds of the global population, may be accelerating neurological decline and increasing dementia risk, according to researchers from The Catholic University of Korea Seoul St.Mary's Hospital. https://lnkd.in/geqyRPN6

Celltrion Inc said Friday that the company’s Brazilian subsidiary has won the @Federal Government of Brazil’s bid to supply #Herzuma (ingredient: trastuzumab) for the fifth consecutive year, with around 660,000 vials to be delivered through 2025. https://lnkd.in/grwc9cMj

Seoul's beauty industry faces a growing issue of non-specialists posing as #dermatologists, misleading patients and causing serious health complications, prompting calls for stricter regulations and public awareness. https://lnkd.in/gAkhARrq